Venus Remedies

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE411B01019
  • NSEID: VENUSREM
  • BSEID: 526953
INR
750.00
-2.9 (-0.39%)
BSENSE

Dec 05

BSE+NSE Vol: 36.22 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Consolidate Half Yearly Results
Sep'25
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Net Sales
329.93
278.71
262.87
282.97
332.37
314.81
161.54
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
329.93
278.71
262.87
282.97
332.37
314.81
161.54
Raw Material Cost
177.84
147.03
172.80
176.84
224.73
200.89
78.73
Purchase of Finished goods
4.13
17.41
7.77
1.85
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-0.51
0.91
-35.11
-4.99
-9.27
-4.00
6.20
Employee Cost
43.28
39.78
34.45
31.50
25.26
23.41
21.32
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
58.85
54.75
54.77
50.29
47.51
63.32
32.81
Other Expenses
0.00
0.00
0.00
0.00
0.01
-0.01
-0.01
Total Expenditure (Excl Depreciation)
283.59
259.88
234.68
255.49
288.24
283.61
139.05
Operating Profit (PBDIT) excl Other Income
46.34
18.83
28.19
27.48
44.13
31.20
22.49
Other Income
5.12
9.52
5.31
3.23
4.84
14.31
2.17
Operating Profit (PBDIT)
51.46
28.35
33.50
30.71
48.97
45.51
24.66
Interest
0.02
0.04
0.12
0.26
0.17
10.25
11.09
Exceptional Items
0.00
0.00
0.00
0.00
0.00
-1.58
0.00
Gross Profit (PBDT)
51.44
28.31
33.38
30.45
48.80
33.68
13.57
Depreciation
12.35
12.39
13.99
16.79
17.33
17.20
17.06
Profit Before Tax
39.09
15.92
19.39
13.66
31.48
16.49
-3.49
Tax
9.36
11.18
8.27
1.44
-3.37
1.49
0.16
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
29.73
4.74
11.12
12.22
34.85
15.00
-3.66
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
29.73
4.74
11.12
12.22
34.85
15.00
-3.66
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
29.73
4.74
11.12
12.22
34.85
15.00
-3.66
Equity Capital
13.37
13.37
13.37
13.37
13.37
12.34
12.34
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
421.91
0.00
0.00
Earnings per share (EPS)
22.24
3.55
8.32
9.14
26.07
12.16
-2.97
Diluted Earnings per share
22.24
3.54
8.32
9.14
26.41
12.15
-2.96
Operating Profit Margin (Excl OI)
14.05%
6.76%
10.72%
9.71%
13.28%
9.91%
13.92%
Gross Profit Margin
15.59%
10.16%
12.7%
10.76%
14.68%
10.7%
8.4%
PAT Margin
9.01%
1.7%
4.23%
4.32%
10.49%
4.76%
-2.27%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2025 is 18.38% vs 6.03% in Sep 2024

stock-summary

Consolidate Net Profit

Growth in half year ended Sep 2025 is 527.22% vs -57.37% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2025 is 146.10% vs -33.20% in Sep 2024

stock-summary

Interest

Growth in half year ended Sep 2025 is -50.00% vs -66.67% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2025 has improved from Sep 2024

Compare Half Yearly Results Of Venus Remedies With
Markets Mojo
Figures in Cr
Consolidate Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
329.93
0
329.93
Other Operating Income
0.00
0.00
0.00
Total Operating income
329.93
0
329.93
Raw Material Cost
177.84
0
177.84
Purchase of Finished goods
4.13
0
4.13
(Increase) / Decrease In Stocks
-0.51
0
-0.51
Employee Cost
43.28
0
43.28
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
58.85
0
58.85
Other Expenses
0.00
0.00
0.00
Total Expenditure (Excl Depreciation)
283.59
0
283.59
Operating Profit (PBDIT) excl Other Income
46.34
0.00
46.34
Other Income
5.12
0
5.12
Operating Profit (PBDIT)
51.46
0
51.46
Interest
0.02
0
0.02
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
51.44
0
51.44
Depreciation
12.35
0
12.35
Profit Before Tax
39.09
0
39.09
Tax
9.36
0
9.36
Provisions and contingencies
0.00
0
0.00
Profit After Tax
29.73
0
29.73
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
29.73
0
29.73
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
29.73
0
29.73
Equity Capital
13.37
0
13.37
Face Value
10.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
22.24
0
22.24
Diluted Earnings per share
22.24
0
22.24
Operating Profit Margin (Excl OI)
14.05%
0%
0.00
14.05%
Gross Profit Margin
15.59%
0%
0.00
15.59%
PAT Margin
9.01%
0%
0.00
9.01%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 329.93 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 18.38% vs 6.03% in Sep 2024

Half Yearly - Consolidate Net Profit
Consolidate Net Profit 29.73 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 527.22% vs -57.37% in Sep 2024

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 46.34 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 146.10% vs -33.20% in Sep 2024

Half Yearly - Interest
Interest 0.02 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is -50.00% vs -66.67% in Sep 2024

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.05%
in Sep 2025

Figures in %
stock-summary

Growth in half year ended Sep 2025 has improved from Sep 2024